Format

Send to

Choose Destination
Clin Chem. 2019 Apr 15. pii: clinchem.2019.303255. doi: 10.1373/clinchem.2019.303255. [Epub ahead of print]

What the Protecting Access to Medicare Act Means for Clinical Laboratories.

Author information

1
Vanderbilt University School of Medicine, Nashville, TN james.h.nichols@vumc.org.
2
AACC, Washington, DC.
3
Assistant Professor Emeritus, Laboratory Medicine and Pathology College of Medicine, Mayo Clinic, Rochester, MN.
4
Professor of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
5
Corporate Medical Director, Quest Diagnostics, Secaucus, New Jersey.
6
Senior Partner, EP Clinical Laboratory Consulting, Blufton, SC.
7
Principal, McDermott + Consulting, LLC, Washington, DC.
8
CEO, CodeMap, Chicago, IL.
9
Director, Corporate Reimbursement, Government Affairs, Abbott Laboratories, Abbott Park, IL.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center